Nektar Therapeutics

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$72.22

-2.62 (-3.50%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target -41.5% upside

Low Target $31.85

Average Target $42.23

High Target $63.47

Current Price $72.22

Current
$72.22

Target
$42.23

$31.85 $42.23 avg $63.47

Scenario Analysis

Bear Case

$31.85

-55.9%

Low target

Base Case

$42.23

-41.5%

Avg target

Bull Case

$63.47

+-12.1%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$75.67

-4.6% from high

52-Week Low

$6.48

+1,014.5% from low

Target vs 52W High

$42.23

-44.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%